Seres Therapeutics, Inc. Annual Operating Lease, Payments in USD from 2019 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.
Summary
Seres Therapeutics, Inc. quarterly/annual Operating Lease, Payments history and growth rate from 2019 to 2023.
  • Seres Therapeutics, Inc. Operating Lease, Payments for the quarter ending September 30, 2024 was $5.36M, a 21.9% increase year-over-year.
  • Seres Therapeutics, Inc. Operating Lease, Payments for the twelve months ending September 30, 2024 was $18.3M, a 29.6% increase year-over-year.
  • Seres Therapeutics, Inc. annual Operating Lease, Payments for 2023 was $15.7M, a 100% increase from 2022.
  • Seres Therapeutics, Inc. annual Operating Lease, Payments for 2022 was $7.81M, a 14.5% increase from 2021.
  • Seres Therapeutics, Inc. annual Operating Lease, Payments for 2021 was $6.82M, a 8.24% increase from 2020.
Operating Lease, Payments, Trailing 12 Months (USD)
Operating Lease, Payments, Annual (USD)
Operating Lease, Payments, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $15.7M +$7.85M +100% Jan 1, 2023 Dec 31, 2023 8-K 2024-08-15
2022 $7.81M +$988K +14.5% Jan 1, 2022 Dec 31, 2022 8-K 2024-08-15
2021 $6.82M +$519K +8.24% Jan 1, 2021 Dec 31, 2021 10-K 2024-03-05
2020 $6.3M -$212K -3.26% Jan 1, 2020 Dec 31, 2020 10-K 2023-03-07
2019 $6.51M Jan 1, 2019 Dec 31, 2019 10-K 2022-03-01
* An asterisk sign (*) next to the value indicates that the value is likely invalid.